Peptide Reconstitution Guide

A structured reference for proper preparation, handling, and storage of research peptides. Designed to support consistency, stability, and reliable laboratory outcomes. For research use only. Not for human or veterinary use.

Proper reconstitution is essential for maintaining peptide stability and ensuring reliable research outcomes. Lyophilised peptides are freeze-dried for long-term preservation, and correct handling helps maintain integrity, reduce contamination risk, and improve experimental consistency.

All preparation steps should be performed in accordance with validated laboratory SOPs to ensure consistency and reproducibility.

Unreconstituted peptides should be stored in controlled conditions to preserve quality. Long-term storage is best maintained in a freezer (≤ -20°C), while refrigeration (2–8°C) is suitable for shorter durations. Room temperature exposure should be limited to brief handling only.

All materials should remain sealed and protected from moisture, light, and temperature fluctuations. Avoid repeated temperature cycling, as fluctuations may reduce peptide stability over time.

Before use, allow both the vial and diluent to reach room temperature. Disinfect vial stoppers and use sterile equipment for handling. Add the required volume of sterile diluent slowly along the vial wall, avoiding direct contact with the powder. Gently swirl until fully dissolved—do not shake aggressively. Once prepared, label the vial with concentration, date, and batch details, then store under appropriate conditions as per protocol.

All concentrations should be calculated in advance and verified prior to reconstitution to ensure accurate experimental preparation.

Lyophilised peptides stored refrigerated can remain stable for 12–24 months, while frozen storage may extend stability beyond 2–4 years. Once reconstituted, solutions should generally be used within 2–8 weeks under refrigeration, depending on compound and solvent conditions.

Aliquoting and freezing may help reduce degradation from repeated freeze–thaw cycles. Actual stability may vary depending on peptide structure, solvent choice, and storage conditions.

Always use sterile, laboratory-grade water and tools. Avoid shaking, vortexing, or introducing contaminants through repeated punctures. Do not use non-sterile water sources or over-dilute solutions, as this may reduce stability and reliability. Maintain aseptic technique at all times during handling. Maintain strict aseptic technique throughout all handling steps to minimise contamination risk and preserve sample integrity.

For more controlled applications, solvent selection and concentration planning should align with experimental design. Some compounds may require pre-solubilisation techniques depending on solubility characteristics. Always follow internal SOPs and validated laboratory procedures for preparation and handling.

All methods should be validated internally prior to experimental use, with full documentation maintained for reproducibility and compliance.